Corticosteroid | Low Risk

Hydrocortisone (Hydrocortisone Viatris 4)

Hydrocortisone risk profile, scheduling, and guidance for claims professionals and care workers . Also known as Hydrocortisone Viatris 4, Hysone 4, Hydrocortisone Viatris 20, Hysone 20.

Source: PBS, TGA Updated April 2026

Hydrocortisone (brand names: Hydrocortisone Viatris 4, Hysone 4, Hydrocortisone Viatris 20, Hysone 20) is classified as Low risk (2 risk points) by AllMeds. It is a S4 medication under the TGA in Australia. Systemic corticosteroid can cause mood changes and impaired judgment affecting work performance.

Key Takeaways

  • TGA Schedule: S4 in Australia
  • Risk level: Low (2 points)
  • Recommended maximum duration: 84 days
  • PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme

Scheduling and Classification

Jurisdiction Classification Status
Australia (TGA) S4 PBS listed

Risk Profile

Risk Level Low
Risk Points 2
CNS Depressant No
Respiratory Risk No
Max Duration 84 days

Systemic corticosteroid can cause mood changes and impaired judgment affecting work performance.

Regulatory and Compliance Guidance

When Hydrocortisone appears on a claimant's medication list, claims professionals should assess whether the prescribing is appropriate for the compensable injury, whether the duration is within guidelines, and whether there are interactions with other medications on the claim.

Australia TGA / PBS / State Schemes

Classified as S4 under the Therapeutic Goods Administration (TGA).

Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.

Need to assess this medication across your caseload?

Run a full risk assessment including Hydrocortisone interactions and compliance checks.

AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.

Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.